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Abstract: Sabicea species are used in the Amazon for treatment of fever and malaria, 
which suggests that its chemical constituents may have some effect on pain and 
inflammation. Phytochemical analysis of the hexane fraction obtained from the crude 
ethanol extract from Sabicea grisea var. grisea Cham. & Schltdl (Rubiaceae), an endemic 
plant in Brazil, resulted in the isolation of octacosanol. This study investigated the 
antinociceptive and anti-inflammatory effects of the octacosanol in different experimental 
models. The crude ethanolic extract and hexane fraction obtained from the leaves of   
S. grisea produced an inhibition of acetic acid-induced pain. Moreover, octacosanol 
isolated from the hexane fraction produced a significant inhibition of pain response elicited 
by acetic acid. Pre-treatment with yohimbine, an alpha 2-adrenergic receptor antagonist, 
notably reversed the antinociceptive activity induced by octacosanol in the abdominal 
constriction test. Furthermore, mice treated with octacosanol did not exhibit any behavioral 
alteration during the hot plate and rota-rod tests, indicating non-participation of the 
supraspinal components in the modulation of pain by octacosanol with no motor 
abnormality. In the formalin test, octacosanol did not inhibit the licking time in first phase 
(neurogenic pain), but significantly inhibited the licking time in second phase 
(inflammatory pain) of mice. The anti-inflammatory effect of octacosanol was evaluated 
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using carrageenan-induced pleurisy. The octacosanol significantly reduced the total 
leukocyte count and neutrophils influx, as well as TNF-α levels in the carrageenan-induced 
pleurisy. This study revealed that the mechanism responsible for the antinociceptive and 
anti-inflammatory effects of the octacosanol appears to be partly associated with an 
inhibition of alpha 2-adrenergic transmission and an inhibition of pathways dependent on 
pro-inflammatory cytokines. Finally, these results demonstrated that the octacosanol from 
the leaves of S. grisea possesses antinociceptive and anti-inflammatory activities, which 
could be of relevance for the pharmacological control of pain and inflammatory processes. 
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1. Introduction 
Octacosanol, a long-chain aliphatic alcohol, found abundantly in wheat germ oil or rice bran oil and 
in many other plants [1], presents a variety of important biological activities, including antioxidant and 
ergogenic properties and anti-parkinsonism [2,3]. In addition, this alcohol and its synthetic analogue, 
octacosa-10,19-dien-1-butanol, both presented an antiangiogenic effect and an inhibition of the activity 
of matrix metalloproteinase [4,5]. Mixtures of long-chain aliphatic alcohols containing octacosanol 
(policosanol) have been shown to decrease the weight of adipose tissue [6] and to inhibit cholesterol 
biosynthesis [7]. Furthermore, studies have shown that policosanol monotherapy reduces LDL-cholesterol 
and increases HDL-cholesterol [8]. Besides these effects on lipid metabolism, policosanol also 
presents a wide range of pharmacological activities, such as reducing platelet aggregation [9], as 
antiulcer [10] and as anti-inflammatory [11,12]. 
Identification of bioactive compounds from plants has become a highly active area of 
pharmaceutical research. Such compounds have been applied in the treatment of different conditions, 
including anxiety, pain, and inflammation [13–15]. Thus, the evaluation of pharmacological effects on 
these conditions can be used as a strategy for discovering new drugs of plant origin. 
Rubiaceae family is considered one of the biggest families among the Angiosperms, comprising 
around 637 genera and approximately 10,700 species, which are of great importance to the food, 
ornamental and pharmaceutical industries [16]. Rubiaceae species are known to be used as 
bioproducers of alkaloids, tannins, saponins, steroids, fatty acids, fatty alcohols, terpenes and 
flavonoids, besides reports that some species are important to traditional medicine [17–19]. 
Considering the wealth of metabolites of the family Rubiaceae, the phytochemical study of species  
that represent the genera of this family, especially of the genus Sabicea whose chemistry is still little 
known, leads are expected in the discovery of naturally active substances although as yet they are  
little explored. 
The genus Sabicea is the most species-rich of the tribe Sabiceae with 146 species of shrubs and 
woody climbers distributed in mainland Africa and the Neotropics [20]. Species of this genus are used 
in folk medicine for treating epilepsy [13], fever, vomiting, insomnia [21], stomach ache, dysentery 
and malaria [22]. In the Amazon, the use for the treatment of fever and malaria suggests that chemical 
constituents present in this genus may have some effect on pain and inflammation. Sabicea grisea Int. J. Mol. Sci. 2012, 13 1600 
 
 
Cham. & Schltdl. var. grisea is endemic in Brazil and until now, no phytochemical or biological study 
has been performed with this species. Based on these observations, the present study used different 
experimental models in mice to test the hypothesis that octacosanol isolated from the leaves of   
S. grisea could demonstrate properties antinociceptive and anti-inflammatory. 
2. Results and Discussion 
2.1. Extraction and Isolation of Octacosanol 
Powder of the dried leaves of S. grisea was extracted at room temperature with 90% ethanol. The 
obtained crude ethanol extract was partitioned between hexane, chloroform and hydro-alcoholic 
solution (7:3). The hexane fraction was further fractionated on a silica gel column. Fractions with 
similar thin layer chromatography profiles were pooled. The remaining fractions were subjected to 
washings with hexane that resulted in the isolation of octacosanol (C28H57OH). Verification of the 
purity of octacosanol was carried out by gas chromatography. The GC data revealed that a major peak 
was eluted at 38.79 min. However, minor impurities (especially hexacosanol at 36.08 min—C26H53OH) 
were also detected as per the GC profile indicating that the compound was about 90% pure (Figure 1). 
Figure 1. Gas chromatogram profile of octacosanol isolated from the leaves of S. grisea. 
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2.2. Writhing Response Induced by Acetic Acid in Mice 
The writhing test has long been used as a screening tool for the assessment of analgesic properties 
of new substances [23]. It is accepted that acetic acid acts by releasing endogenous substances, such as 
prostaglandins and cytokines, which excite primary sensor neurons [24]. In this study, the crude 
ethanol extract and its sequential fraction in hexane from S. grisea at 100 mg/kg (i.p.) significantly Int. J. Mol. Sci. 2012, 13 1601 
 
 
reduced the number of writhes (to 8.25 ± 2.65 and 9.50 ± 5.70 abdominal writhes), respectively, in 
relation to the control group (37.00 ± 3.74 abdominal writhes). Administration of octacosanol (0.1, 1 
and 10 mg/kg, i.p.), 60 min before the acid injection, produced a significant inhibition of abdominal 
constrictions in mice (Figure 2). The percentage of inhibition produced by octacosanol at all three 
doses tested  was 22.5, 58.1, and 63.9%, respectively, compared to the control. This was also 
comparable with indomethacin (20 mg/kg, i.p.), a standard nonsteroidal anti-inflammatory drug used as 
positive control, that also produced a significant inhibition (72.9%). In fact, acetic acid causes an 
increase in peritoneal fluid levels of prostaglandin E2 (PGE2) and prostaglandin F2 (PGF2), in part 
involving peritoneal receptors and causing inflammatory pain by inducing capillary permeability [25]. 
Thus, our results suggest that the action of octacosanol may be linked partly to the inhibition of 
cyclooxygenase in peripheral tissues, thereby reducing PG synthesis and interfering with the 
mechanism of transduction in primary afferent nociceptors. In addition, this data suggests octacosanol 
is one of the main active compounds present in the leaves of S. grisea. 
Figure 2. Effect of the octacosanol on acetic acid-induced writhing response in mice. The 
values are expressed as the mean ± S.E.M. of six mice. * P < 0.05 and ** P < 0.01 indicate 
statistically significant differences from the saline-treated group. 
 
To assess the possible mechanisms of antinociceptive activity of the octacosanol, we examined the 
effects of naloxone, yohimbine and atropine on the writhing test induced by acetic acid. The results 
presented in Figure 3 show that pre-treatment of the mice with yohimbine (1 mg/kg), an alpha  
2-adrenergic receptor antagonist, was able to partially revert the antinociceptive effect of octacosanol 
(10 mg/kg, i.p.), suggesting a possible involvement of alpha 2-adrenergic receptors in the actions 
of  octacosanol. 
The opiate mechanism was analyzed by testing the effect of naloxone on the octacosanol-induced 
antinociception. The dose of naloxone used in the experiments was high enough to block opiate 
receptors [26]. In the present study, naloxone was completely inactive as antagonist, thus precluding 
involvement of the central opiate mechanism in the antinociception of octacosanol (Figure 3). Int. J. Mol. Sci. 2012, 13 1602 
 
 
Similarly, a muscarinic-mediated mechanism can also be excluded due to the lack of antagonism by 
atropine (Figure 3). 
Figure 3. Effect of pretreatment of animals with yohimbine (2 mg/kg, s.c.), naloxone   
(5 mg/kg, s.c.) and atropine (2 mg/kg, s.c.) on the antinociceptive profile of the octacosanol 
against acetic acid-induced writhing in mice. 
+ P < 0.001, indicate statistically significant 
differences compared to untreated group. * P < 0.05, indicate statistically significant 
differences compared to octacosanol-treated group. Under the graph, the signs + and - 
indicate the presence or absence of the respective treatment. 
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In fact, the roles of opioid, muscarinic and adrenergic receptors in the regulation of the modulation 
of nociceptive processing have been demonstrated in several previous studies [27–29]. Here, we 
observed that alpha 2-adrenergic receptors, but not opioid and muscarinic receptors, appear to be 
involved in octacosanol-induced antinociception. 
2.3. Effect on Rota-Rod Assay in Mice 
The writhing test shows good sensitivity, as it allows for the effects of weak analgesics, but it does 
show poor specificity because the abdominal writhing response may be suppressed by muscle relaxants  
and other drugs, leaving scope for the misinterpretation of results [30]. This can be avoided by 
complementing the test with other models of nociception and a motility test. For this reason, octacosanol 
was examined for its inhibitory action on motility in the rota-rod test. The rota-rod procedure was 
described by Dunham and Miya [31] and is suitable for detecting motor impairment due to 
pharmacological agents such as skeletal muscle relaxants or central nervous system depressants. In this 
study, octacosanol-treated mice did not show any significant motor performance alterations with the 
dose of 10 mg/kg i.p. (232.02 ± 39.00 s) as compared to saline-treated animals (205.33 ± 37.97 s) in 
the rota-rod test. As expected, diazepam (positive control, 10 mg/kg, i.p.), the most widely used 
benzodiazepine derivative, that causes sedation and inhibits locomotor activity, reduced the motor Int. J. Mol. Sci. 2012, 13 1603 
 
 
performance time of mice after 30 min of treatment (66.25 ± 15.39 s). Thus, as octacosanol did not 
affect the motor performance of mice in the rota-rod test, the effects of relaxing or motor deficits  
could be excluded. 
2.4. Effect on Hot-Plate Latency Assay in Mice 
It has been well documented that the hot plate is a central antinociceptive test in which opioid 
agents exert their analgesic effects via supraspinal and spinal receptors [30]. In this assay, octacosanol 
(1 and 10 mg/kg, i.p.) did not exert any significant changes in the response of latency (9.41 ± 2.29 and 
10.08 ± 1.15 s, respectively) against the thermal stimulus-induced nociception, as compared to control 
(7.03 ± 0.88 s), while morphine (positive control; 5 mg/kg, i.p.) significantly increased the latency 
response (18.99 ± 1.41 s). The treatment with octacosanol was found to induce an antinociceptive 
response in the abdominal writhing test. This treatment was ineffective on the hot plate test which 
indicates a non-participation on thermal stimulation associated with central neurotransmission whereby 
heat activates nociceptors by driving the momentum of the dorsal horn of the spinal cord which 
subsequently affects cortical centers. 
2.5. Effects on Formalin-Induced Nociception in Mice 
The formalin-induced paw licking test is commonly employed as a model of acute tonic pain, 
characterized by the presence of a distinct biphasic nociceptive response. The first phase corresponds 
to neurogenic pain as it involves direct activation of formalin on transient receptor, sensory C-fibers, 
that reflect centrally mediated pain [32]. The second phase of the nociceptiva reaction, also known as 
inflammatory pain, is mediated by a combination of peripheral input from inflammatory mediators 
released from injured tissues, which result in the sensitization of central nociceptive neurons [33]. It 
was reported that substance P and bradykinin participate in the appearance of the first-phase responses, 
while histamine, serotonin, prostaglandin and bradykinin are involved in the second-phase responses. 
It has been well established that drugs that act primarily on the central nervous system inhibit both 
phases equally, while peripherally acting drugs inhibit only the second phase [34]. 
In the present study, the licking time for the first phase was 44.00 ± 6.00 s and for the second phase 
218.66 ± 23.73 s in control groups (vehicle). Using the two higher doses (1 and 10 mg/kg) able to 
inhibit nociceptive stimulus induced by acetic acid, the pretreatment of animals for 60 min with 
octacosanol had no significant effect on the duration of licking activity in first phase (37.20 ± 8.98 s and 
31.00 ± 6.36 s, respectively), whereas both doses produced a marked reduction of the duration of the 
licking in the second phase (152.75 ± 23.97 s and 67.25 ± 21.97 s, respectively). Indomethacin   
(20 mg/kg), a reference drug, significantly inhibited the pain only in the second phase of the test  
(63.40 ± 15.35 s). Thus, our results showed that octacosanol suppressed the nociceptive response in the 
inflammatory phase but not in the neurogenic phase of the formalin test (Figure 4). Int. J. Mol. Sci. 2012, 13 1604 
 
 
Figure 4. Effect of octacosanol (1 and 10 mg/kg) and indomethacin (positive control;   
20 mg/kg, i.p.) on nociception induced by formalin during the first 5 min (1
st phase), and 
during 15–30 min (2
nd phase). Data are expressed as mean ± SEM (n = 6). * P < 0.05 and 
*** P < 0.001 compared to respective saline-treated group. 
 
2.6. Effects on Carrageenan-Induced Pleurisy in Mice 
Pleurisy induced by phlogistic agents is a widely accepted model for the evaluation of the   
anti-inflammatory effect of compounds obtained from plants [35]. To assess the anti-inflammatory 
activity, octacosanol was evaluated by the carrageenan-induced pleurisy model. Carrageenan-induced 
pleurisy is a classical model of acute inflammation involving various types of chemical mediators of 
inflammation such as vasoactive amines, complement fragments, prostaglandins, and cytokines [36]. 
The administration of carrageenan into the pleural space is characterized by protein-rich fluid   
accumulation and polymorphonuclear leukocytes infiltration, which are important processes of   
inflammatory pathology [35]. 
As shown in Table 1, substantially fewer leukocytes were observed in animals injected with vehicle. 
Administration of carrageenan into the pleural space of mice induced an increase in total leukocyte 
count, characterized by an increase in the number of neutrophil and mononuclear cells 4 h after 
injection. Treatment with octacosanol, administrated 1 h before carrageenan, at doses of 1 and   
10 mg/kg i.p., was able to suppress significantly the recruitment of total leukocytes to the mouse 
pleural cavity. 
Table 1. Effect of octacosanol on total leukocyte, neutrophil and mononuclear cells 
induced by carrageenan in the pleural cavity of mice. 
Groups of animals 
Total leukocytes 
(×10
6 cells/cavity) 
Neutrophils 
(×10
6 cells/cavity)
Mononuclear cells
(×10
6 cells/cavity) 
Basal  1.86 ± 0.14  0.12 ± 0.13  1.74 ± 0.16 
Cg  11.85 ± 2.19 
+++  8.05 ± 1.34 
+++  3.22 ± 0.39 
+ 
Cg + Octacosanol (1 mg/kg)  5.70 ± 1.34 **  2.74 ± 0.53 ***  2.89 ± 0.34 
Cg + Octacosanol (10 mg/kg)  4.68 ± 0.51 ***  2.22 ± 0.22 ***  2.45 ± 0.36 
Cg + Indomethacin (20 mg/kg)  3.26 ± 0.48 ***  1.24 ± 0.18 ***  1.83 ± 0.36 
Each value represents the mean ± S.E.M. of six animals; Basal = animals that received injection of vehicle  
in the cavity; Cg = carrageenan; 
+ P < 0.05 and 
+++ P < 0.001 as compared to saline-stimulated group;  
** P < 0.01 and *** P < 0.001 as compared to untreated (saline) stimulated group. Int. J. Mol. Sci. 2012, 13 1605 
 
 
Others studies have demonstrated that mixtures of aliphatic alcohols are effective in preventing the 
neutrophil infiltration in the inflamed tissue [12]. In fact, Carbajal et al. [37] reported that a natural 
mixture of high molecular weight alcohols shows an anti-inflammatory activity which is effective in  
both chronic and acute inflammation. Here, our study demonstrated that octacosanol was able to 
inhibit the neutrophils influx in mice, but did not alter mononuclear cells migration in the   
carrageenan-induced pleurisy. 
The intrapleural administration of carrageenan into the pleural space induces non-specific 
inflammatory reactions, which induce the activation of innate immunity and the peripheral release of 
tumor necrosis factor-alpha (TNF-α) [38]. The TNF-α has been shown to have many biological 
activities in the inflammatory reaction, including fever, accumulation of neutrophils in local tissues, 
induction of vascular adhesion molecules and stimulation of acute phase protein synthesis [39]. Our 
results show that 4 h after the injection of carrageenan a substantial increase in the amount of TNF-α 
was found in pleural exudates when compared with saline injected mice (Table 2). A significant 
reduction in TNF-α concentration was observed in the treated group with octacosanol (1 and 10 mg/kg, 
i.p.) and indomethacin (20 mg/kg, i.p.) as compared to the carrageenan-treated group. 
Table 2. Effect of octacosanol on tumor necrosis factor-alpha (TFNα) levels in the pleurisy 
induced by carrageenan in mice. 
Groups of animals  TNF-α (pg/mL)  Inhibition (%) 
Basal  19.53 ± 11.49  - 
Cg  164.50 ± 50.99 
++ - 
Cg + Octacosanol (1 mg/kg)  22.56 ± 14.80 **  86.28 
Cg + Octacosanol (10 mg/kg)  24.17 ± 12.50 **  85.30 
Cg + Indomethacin (20 mg/kg)  19.15 ± 4.43 **  88.35 
Each data represents the mean ± S.E.M. of six mice; Basal = animals that received injection of vehicle in  
the cavity; Cg = carrageenan; 
++ P < 0.01 as compared to saline-stimulated group; ** P < 0.01 as compared to 
untreated (saline) stimulated group. 
Many studies have shown that fatty alcohols also reduce the TNF-α production in both in vitro and 
in vivo [11,40]. Together, our results show that the octacosanol inhibited the influx of total leukocytes 
into the pleural cavity triggered by carrageenan, due to the inhibition of neutrophils recruitment. In 
addition, this compound showed the ability to decrease TNF-α in the pleural fluid of mice with 
carrageenan-induced inflammation. 
3. Experimental Section 
3.1. Plant Material 
Leaves of Sabicea grisea Cham. & Schltdl. var. grisea were collected in May 2008, at the Horto 
Municipal de Maceió, Alagoas State, Brazil, and identified by Rosangela P. L. Lemos of the Instituto 
do Meio Ambiente do Estado de Alagoas, where a voucher specimen was deposited (MAC-11356). Int. J. Mol. Sci. 2012, 13 1606 
 
 
3.2. Preparation of Extracts, Purification and Structure Elucidation of Octacosanol 
Powder of the dried leaves of S. grisea was extracted at room temperature with 90% ethanol. The 
solution was filtered using a Whatman N° 1 filter paper under suction and concentrated to dryness at  
50 °C under reduced pressure. The obtained crude ethanol extract was partitioned between hexane, 
chloroform and hydro-alcoholic solution (7:3). The hexane fraction was further fractionated on a silica 
gel column using hexane, containing increasing amounts of ethyl acetate. The remaining fractions were 
subjected to washings with hexane that resulted in the isolation of octacosanol (45 mg), m.p. 81–82 °C. 
The concentration of octacosanol was 88.23 µg per 1 g dry weight of leaves. This compound was 
structurally characterized based on its GC-MS, and 
1H and 
13C NMR analyses together with available  
literature [41,42]. GC-MS analysis of octacosanol was carried out with instrument GC–MS system 
(Varian 3200 and Finnigam Incos-XL) under the following conditions: DB-5 fused silica column   
(30 m length, 0.25 mm i.d., 0.25 mm film thickness); injector temperature, 220 °C; temperature 
programmed at 60–270 °C at 3 °C/min; injection type, splitless (1 μL of a 1:1000 n-hexane solution); 
carrier gas, helium, adjusted to a linear velocity of 32 cm/s (measured at 100 °C); mass spectra, 70 eV, 
in EI mode; ion source temperature, 180 °C; scan mass range, 25–700 u. 
Immediately prior to use, the crude ethanolic extract, hexane fraction and octacosanol were 
dissolved in 200 μL of absolute ethanol and 3800 μL of saline (NaCl, 0.9%) to make a concentration of 
2 mg/mL, which was diluted to achieve the required concentrations for subsequent experiments.  
3.3. Animals 
Male Swiss mice weighing 18–22 g were provided by the Central Biotery of Universidade Federal 
de Alagoas (UFAL) breeding unit. The animals were maintained with free access to food and water 
and kept at 22 ± 2 °C with a controlled 12 h light-dark cycle at Instituto de Ciências Biológicas e da 
Saúde. Experiments were performed during the light phase of the cycle. The animals were allowed to 
adapt to the laboratory for at least 2 h before testing and used only once. Animal care and the 
experimental protocol followed the principles and guidelines outlined by the Brazilian College of 
Animal Experimentation (COBEA) and were approved by the local ethical committee (License no. 
23065.009301/2009-96). 
3.4. Acetic Acid-Induced Writhing Response in Mice 
Antinociceptive activity was evaluated using the test of abdominal writhing induced by acetic acid 
in mice [23]. Abdominal writhing in mice was caused by the intraperitoneal (i.p.) injection of 0.6% 
acetic acid, 0.1 mL/10 g body weight. Animals were divided into groups of six mice. Control animals 
received an i.p. injection of the same volume of vehicle (saline, NaCl 0.9%). One group of mice 
received indomethacin (20 mg/kg, i.p.) as a reference compound, and the other three groups received 
different doses of octacosanol (0.1, 1 and 10 mg/kg body weight, i.p.) 60 min before stimulation with 
acetic acid. The doses of octacosanol used in this study were obtained from previous reports [3,43]. 
Solutions containing octacosanol were placed on ultrasound for 5 min, before using. Five minutes after 
the acetic acid injection, the number of times that each animal presented abdominal constriction was Int. J. Mol. Sci. 2012, 13 1607 
 
 
counted for 10 consecutive min. The percentage of inhibition was determined for each experimental 
group using the following formula [14]: 
Inhibition % = 100 − T × 100/C(%) or T × 100/C − 100(%) 
Where C and T indicate non-treated (vehicle) and drug-treated, respectively. 
3.5. Analysis of Possible Antinociceptive Mechanisms of Octacosanol 
To assess the possible mechanisms involved in the antinociceptive action of octacosanol, mice were 
previously treated with different antagonists in the acetic acid model. To determine the possible 
participation of different systems, the following antagonists were used; naloxone (5 mg/kg), atropine 
(5 mg/kg), and yohimbine (1 mg/kg), administered subcutaneous (s.c.) 15 min before the octacosanol 
(10 mg/kg, i.p.). All the reagents were obtained from Sigma. 
3.6. Hot-Plate Latency Assay in Mice 
The hot-plate test was used to measure reaction times according to the method described by Eddy 
and Leimback (1953) [44]. Animals were placed individually on a hot plate metallic surface (Insight
®, 
Brazil; model EFF-361) maintained at 54 ± 1 °C, and the time between placement of the animal on the 
hot plate and the occurrence of either licking of the hind paws, shaking, or jumping off the surface was 
recorded as reaction time (s). Reaction time was measured at 60 min following treatment with saline 
(i.p.), octacosanol (1 and 10 mg/kg, i.p.) or morphine (5 mg/kg, i.p.), with a cut-off time of 20 s. Each 
experimental group contained at least six animals. 
3.7. Formalin-Induced Nociception in Mice 
Mice were injected with formalin (2.5%, 20 µL) in the subplantar area of the right hind paw. The 
time of paw licking (in seconds) was determined over 0–5 min (first phase—neurogenic) and   
15–30 min (second phase—inflammatory) after formalin injection [34]. Animals (n = 6) were 
pretreated with octacosanol (1 and 10 mg/kg, i.p.) 60 min before intraplantar injection of the stimulus 
or the reference compound, indomethacin (20 mg/kg, i.p.), 1 h before administration of formalin. 
Control animals were treated with sterile saline. 
3.8. Rota-Rod Assay 
The motor coordination of the animals was evaluated in a rota-rod apparatus (Insight
®, Brazil; 
model EFF-412). The animals were trained on the apparatus for 2 days before the experiment. On the 
day of the experiment, mice were treated with octacosanol (10 mg/kg, i.p.) or diazepam (10 mg/kg, i.p) 
and tested in the rota-rod from 60 min after their administration [31]. After treatment, the motor 
performance time (s) was recorded with a stopwatch for up to 240 s. 
3.9. Carrageenan-Induced Pleurisy in Mice 
Pleurisy was induced in mice by intrapleural (i.pl.) administration of 100 μL of 1% (w/v) 
carrageenan suspension in saline solution. A specially adapted 13 × 5 needle was introduced into the Int. J. Mol. Sci. 2012, 13 1608 
 
 
right side of the thoracic cavity of mice to inject the carrageenan solution, and an equal volume of 
sterile saline was injected into the controls. After 4 h of the carrageenan suspension, the animals were 
sacrificed in a CO2 gas chamber and the thoracic cavity was opened and washed with 1 mL of PBS 
containing EDTA (10 mM). Pleural wash samples were diluted in Turk fluid (2% acetic acid) for total 
leukocyte counts using Neubauer chambers. Cytospin preparations of the samples were stained with 
May–Grunwald–Giemsa for the differential leukocyte count, which was performed under the 
immersion objective of a light microscope. The animals (six in each group) were pre-treated via the 
intraperitoneal (i.p.) route with octacosanol (1 and 10 mg/kg, i.p.) 60 min prior to the induction of 
pleurisy. Thus, parallel groups of animals were pre-treated (60 min before pleurisy induction) with 
indomethacin (20 mg/kg, i.p.) and 4 h later the same inflammatory parameters were evaluated. 
3.10. Quantification of TNF-α in Carrageenan-Induced Pleurisy 
Levels of tumor necrosis factor-alpha (TNF-α) in the pleural fluid of the animals treated with 
octacosanol (1 and 10 mg/kg, i.p.) and indomethacin (20 mg/kg, i.p.) were evaluated by sandwich 
ELISA, using mouse TNF-α ELISA Ready-SET-Go reagent set (eBioscience) (San Diego, CA, USA), 
according to the manufacturer’s instructions. 
3.11. Statistical Analysis 
Data are reported as mean ± standard error of the mean (SEM) and were analyzed with the use of 
GraphPad Prism
® software, version 5.0 (San Diego, CA, USA). Statistical differences between groups 
were determined when necessary using Student’s t test or via two-way analysis of variance followed 
by Student-Neuman-Keuls test. P values less than 0.05 were considered statistically significant.  
4. Conclusions  
The present study demonstrated, for the first time, that octacosanol, a long-chain aliphatic alcohol 
isolated from the leaves of Sabicea grisea var. grisea, possesses a peripheral antinociceptive effect that 
is probably mediated by the alpha 2-adrenergic receptors. Furthermore, this compound inhibited   
both the influx leuckocyte as well as levels of TNF-α in the carrageenan-induced pleurisy model. 
Based on these findings, octacosanol may be useful in developing new strategies for preventing pain  
and inflammation. 
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